Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vistagen Therapeutics Inc
(NQ:
VTGN
)
3.390
-0.010 (-0.29%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vistagen Therapeutics Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 19, 2022
Via
Benzinga
Why Crypto-Related Stocks Are Trading Lower: Here Are 34 Stocks Moving Premarket
August 19, 2022
Gainers
Via
Benzinga
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Releases Q1 2023 Financial, Corporate Report
August 12, 2022
Via
Investor Brand Network
Exposures
Product Safety
Earnings Scheduled For August 11, 2022
August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
Via
Benzinga
VistaGen Says Data From Late-Stage Anxiety Study 'Not Consistent' With Prior Positive Phase 2 Study
July 22, 2022
Via
Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
August 18, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 11, 2022
Via
Benzinga
VistaGen Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
August 11, 2022
From
VistaGen Therapeutics, Inc.
Via
Business Wire
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) to Host Conference Call to Discuss FY 2023 Q1 Financial Results
August 09, 2022
Via
Investor Brand Network
VistaGen Therapeutics to Report Fiscal Year 2023 First Quarter Financial Results on August 11, 2022
August 09, 2022
From
VistaGen
Via
Business Wire
Vistagen Therapeutics Shares Are Falling Sharply: Here's Why
July 26, 2022
Vistagen Therapeutics Inc (NASDAQ: VTGN) shares are trading lower by 7.57% to $0.16 Tuesday morning after Maxim Group downgraded the stock from Buy to Hold. What Else?
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022
July 26, 2022
Upgrades
Via
Benzinga
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday
July 26, 2022
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
July 25, 2022
Gainers
Via
Benzinga
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
July 25, 2022
Gainers
Via
Benzinga
Recap Of Friday's Biotech Catalysts - End Of The Day Summary
July 22, 2022
Via
Benzinga
Dow Dips More Than 200 Points; Crude Oil Moves Lower
July 22, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Friday.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
July 22, 2022
During Friday's session, 61 companies made new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
July 22, 2022
Via
Benzinga
Why Is Pagaya Technologies (PGY) Stock Soaring 94% Today?
July 22, 2022
Pagaya Technologies (PGY) stock is rocketing higher on Friday despite a lack of news from the financial tech company today.
Via
InvestorPlace
Nasdaq Drops Around 200 Points; Hanger Shares Spike Higher
July 22, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 200 points on Friday.
Via
Benzinga
This Consumer Defensive Stock Is Trading Higher By Around 49%, Here Are 46 Stocks Moving In Friday's Mid-Day Session
July 22, 2022
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares gained 93% to $10.32. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Via
Benzinga
VistaGen Therapeutics (VTGN) Stock Plunges on Disappointing Clinical Data
July 22, 2022
VistaGen Therapeutics (VTGN) stock is falling hard on Friday after the company reported poor results from a Phase 3 study.
Via
InvestorPlace
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Topline Results from PALISADE-1 Phase 3 Clinical Trial for PH94B
July 22, 2022
Via
Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For July 22, 2022
July 22, 2022
Upgrades
Via
Benzinga
Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset
July 22, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
VistaGen Announces Topline Results from PALISADE-1 Phase 3 Clinical Trial for Investigational Drug PH94B
July 22, 2022
From
VistaGen Therapeutics, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
July 19, 2022
Tuesday saw 37 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
July 15, 2022
On Friday, 137 stocks made new 52-week lows.
Via
Benzinga
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) to Participate at 2022 Concordia Americas Summit; CEO and US Surgeon General to Discuss Mental Health Crisis
July 12, 2022
Via
Investor Brand Network
Exposures
COVID-19
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.